3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
EMPA-REG OUTCOME - Empagliflozin ... DECLARE-TIMI 58 - Dapagliflozin ... EMPEROR-REDUCED - Empagliflozin ... SGLT2 #inhibitors #EBM ... visualabstract #table
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
Dapagliflozin in ... those who received dapagliflozin ... or absence of diabetes ... Kosalan Akilan #Dapagliflozin ... #ebm
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
drug to remain stable ... compared to SGLT2 empagliflozin ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology